大型抑郁症患者肠道微生物群和代谢表型的特征,基于多omics分析
Xianpeng Zu1, Jiayun Xin2, Haisheng Xie1
1School of Pharmacy, Naval Medical University, Shanghai 200433, China.
Journal of affective disorders
|October 20, 2023
概括
这项研究揭示了主要抑郁症 (MDD) 中明显的代谢和肠道微生物群差异. 这些发现提供了通过调节肠道菌群来治疗抑郁症的潜在生物标志物和目标.
科学领域:
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
- 微生物组研究的研究.
背景情况:
- 重度抑郁症 (MDD) 是一种具有多种症状的慢性精神疾病.
- 了解MDD的潜在生物机制对于诊断和治疗至关重要.
研究的目的:
- 鉴定MDD无药患者的代谢和肠道菌群的特征.
- 为了确定MDD的潜在诊断生物标志物.
- 探索肠道微生物群和MDD中的代谢障碍之间的关系.
主要方法:
- 57名MDD患者和57名对照患者的血清和尿液代谢量.
- 便16S rDNA测序用于肠道微生物群分析.
- 斯皮尔曼相关性与关联的微生物群和代谢概况.
主要成果:
- 在MDD患者和健康对照者之间观察到血清和尿液代谢的显著差异.
- 特定的代谢途径 (例如,糖脂,胆酸,脂肪酸代谢) 被破坏.
- 在MDD患者中,肠道微生物群的组成发生了显著的变化,与代谢障碍相关.
- 确定了潜在的诊断生物标志物,包括肉和脂肪酸等级.
结论:
- 肠道微生物群失衡与MDD中的代谢功能障碍有关.
- 这些发现支持了肠-大脑轴在抑郁症发病过程中的作用.
- 这项研究为新的诊断工具和针对微生物群的抑郁症治疗提供了基础.
更多相关视频
09:52A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
Published on: January 10, 2025
628
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
8.3K
相关概念视频
Depressive Disorders: Etiology
104
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
104
Depression: Overview
256
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
256
Depressive Disorders: MDD and Dysthymia
138
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
138
Antidepressant Drugs: MAOIs and Other Agents
254
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
254
